What is Rest Ez Inc. (RTEZ)?

Rest Ez Inc. (RTEZ) is a stock in the Healthcare sector, Medical - Pharmaceuticals industry. View full analysis on Stocks360.

What is the current price of RTEZ?

The current price of RTEZ is $70.00. Prices are updated in real time on Stocks360.

What is RTEZ's price-to-earnings (PE) ratio?

RTEZ's trailing twelve-month PE ratio is 0.00, based on current price and earnings per share data available on Stocks360.

What is RTEZ's market capitalization?

RTEZ's market capitalization is $4,200,000,000.00, placing it in the mid-cap tier.

Rest Ez Inc. (RTEZ)

Stock analysis · OTC · Healthcare · Medical - Pharmaceuticals

$70.00

Market Cap

$4.20B

PE (TTM)

0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.23

Day Range

$1.00 – $70.00

52-wk Range

$1.00 – $70.00

Avg Volume

N/A

Volume

100.00

Rest Ez Inc. (RTEZ) is a publicly traded company in the Healthcare sector. Latest price: $70.00. Market cap $4.20B. Trailing PE 0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-31 · $70.00 2026-10-26 · $70.00 (+0.00%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Rest Ez Inc.

Rest Ez Inc. specializes in the production and distribution of sleep-enhancing soft gel capsules throughout the United States. The company's flagship product, also named "Rest EZ," is a soft gel dietary supplement formulated to aid sleep. These offerings are made accessible to consumers via a multi-channel sales strategy, encompassing both wholesale and retail partnerships, as well as direct purchases through its dedicated e-commerce website, www.RestEz.net. Established in 2016, Rest Ez Inc. operates from its headquarters located in Riverton, Utah.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	0.00×
P/S (TTM)	0.00×
P/B	-133.86×
P/FCF (TTM)	0.00×
EV / EBITDA	0.00×
EV / Sales	0.00×
Earnings Yield	0.00%
Free Cash Flow Yield	0.00%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$4.20B
Net Income (TTM)	$0.00
Free Cash Flow (TTM)	$0.00
Net Debt	-$3.86K
Working Capital	-$14.40K
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Return on Equity	0.00%
Return on Invested Capital	0.00%